HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells

导出原文传递

翻译打印收藏纠错

作者： Petri B.J. ^[1] ; Piell K.M. ^[2] ; South Whitt G.C. ^[3] ; Wilt A.E. ; Poulton C.C. ; Lehman N.L. ; Clem B.F. ; Nystoriak M.A. ; Wysoczynski M. ; Klinge C.M.

作者单位： Department of Medicine University of Louisville School of Medicine ^[1] Department of Pathology and Laboratory Medicine University of Louisville School of Medicine ^[2] Department of Biochemistry and Molecular Genetics University of Louisville School of Medicine ^[3]

关键词 Breast cancer Endocrine resistance ER Fulvestrant Tamoxifen

发布时间 2022-03-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer letters

2021年518卷

152-168页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells

Cancer letters

相似文献

Cancer letters

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells

Cancer letters

相似文献

Cancer letters

相关期刊

检索历史清除